According to
GuruFocus list of 52-week highs
, these Guru stocks have reached their 52-Week Highs: The Home
Depot, Inc. (
HD
), Marsh & McLennan Companies, Inc. (
MMC
), 3M Co (
MMM
), Mylan Inc. (
MYL
), and Pfizer Inc. (
PFE
).
The Home Depot Inc. (
HD
) Reached the 52-Week High of $56.76
The prices of The Home Depot Inc. shares have reached $56.76,
which is 0.4% off the 52-week high of $56.96. Home Depot is the
one of world's largest home improvement retailer. The Home Depot,
Inc. has a market cap of $86.87 billion; its shares were traded
at around $56.76 with a P/E ratio of 20.56 and P/S ratio of 1.23.
The dividend yield of The Home Depot, Inc. stocks is 2.04%. The
Home Depot, Inc. had an annual average earnings growth of 5.3%
over the past 10 years.
On Aug. 14, The Home Depot reported second quarter of fiscal 2012
net earnings of $1.5 billion, or $1.01 per diluted share,
compared with net earnings of $1.4 billion, or $0.86 per diluted
share, in the same period of fiscal 2011. For the second quarter
of fiscal 2012, diluted earnings per share increased 17.4 percent
from the same period in the prior year.
In August, Chairman & CEO
Francis S Blake
, CFO & EVP - Corp. Services
Carol B Tome
, EVP - Human Resources
Timothy M Crow
, and EVP - U.S. Stores Marvin R Ellison sold shares of HD stock.
EVP & CIO Matt Carey and EVP - Merchandising Craig A Menear
sold shares in March.
Marsh & McLennan Companies, Inc. (
MMC
) Reached the 52-Week High of $34.17
The prices of Marsh & McLennan Companies, Inc. shares have
reached $34.17, which is 0.5% off the 52-week high of $34.35.
Marsh & McLennan is primarily a holding company which,
through its subsidiaries and affiliates, provides clients with
analysis, advice and transactional capabilities in the fields of
risk and insurance services, investment management and
consulting. Marsh & McLennan Companies, Inc. has a market cap
of $18.64 billion; its shares were traded at around $34.17 with a
P/E ratio of 17.8 and P/S ratio of 1.62. The dividend yield of
Marsh & McLennan Companies, Inc. stocks is 2.69%.
On Aug. 7, Marsh & McLennan Companies, Inc. reported
financial results for the second quarter, ended June 30, 2012.
Consolidated revenue in the second quarter of 2012 was $3
billion, an increase of 3%, or 5% on an underlying basis from the
second quarter of 2011. Operating income rose 11% to $518
million. Adjusted operating income, which excludes noteworthy
items as presented in the attached supplemental schedules, rose
13% to $523 million in the second quarter. Income from continuing
operations in the second quarter of 2012 was $339 million, or
$.60 per share, compared with $286 million, or $.50 per share, in
the second quarter of 2011. Net income was $329 million, compared
with $282 million in the second quarter of 2011.
Last month, President & CEO, Marsh Peter Zaffino sold 56,000
shares of MMC stock. President & CEO, Guy Carpenter Alexander
S Moczarski sold 35,000 shares in June. Vice Chairman, Office of
CEO David A Nadler, EVP & CFO Vanessa Ames Wittman, and SVP
and Controller Robert J Rapport sold shares in March.
3M Co (
MMM
) Reached the 52-Week High of $92.61
The prices of 3M Company shares have reached $92.61, which is
1.8% off the 52-week high of $94.24. 3M Company is a diversified
technology company with positions in consumer and office; display
and graphics; electronics and telecommunications; health care;
industrial; safety, security and protection services;
transportation and other businesses. 3M Company has a market cap
of $64.25 billion; its shares were traded at around $92.61 with a
P/E ratio of 15.13 and P/S ratio of 2.17. The dividend yield of
3m Co stocks is 2.55%. 3M Company had an annual average earnings
growth of 8.4% over the past 10 years. GuruFocus rated 3M Company
the business predictability rank of 3.5-star.
On Apr 24, 3M reported record first-quarter sales of $7.5
billion, up 2.4 percent year-on-year. Earnings were $1.59 per
share, an increase of 6.7 percent versus the first quarter of
2011, and operating margins for the quarter were 21.8 percent.
First-quarter net income rose 4.0 percent year-on-year to over
$1.1 billion and earnings were $1.59 per share, an increase of
6.7 percent versus last year's first quarter. Total-company
operating income margins were 21.8 percent for the quarter, with
five business segments above 20 percent, and free cash flow was
$567 million.
Last month, EXEC VP R&D & CHF TECH OFF Fred J Palensky
and EXEC VP HEALTH CARE Brad T Sauer sold shares of MMM stock.
VICE PRESIDENT CORP SC OPERTNS John K Woodworth sold 30,532
shares in May.
Mylan Inc. (
MYL
) Reached the 52-Week High of $23.56
The prices of Mylan Inc. shares have reached $23.56, which is
1.4% off the 52-week high of $23.88. Mylan Inc. is one of the
world's quality generic and specialty pharmaceutical companies.
Mylan Inc. has a market cap of $10.1 billion; its shares were
traded at around $23.56 with a P/E ratio of 10.71 and P/S ratio
of 1.65. Mylan Inc. had an annual average earnings growth of
29.3% over the past 10 years. GuruFocus rated Mylan Inc. the
business predictability rank of 2-star.
On July 26, Mylan Inc. announced its financial results for the
three months ended June 30, 2012. Adjusted diluted EPS of $0.60
for the three months ended June 30, 2012 compared to $0.52 for
the same prior year period, an increase of 15%. Total revenues of
$1.69 billion for the three months ended June 30, 2012 compared
to $1.57 billion for the same prior year period, an increase of
7%. On a GAAP basis, diluted EPS of $0.33 for both of the three
month periods ended June 30, 2012 and 2011.
Last month, President, North America Anthony Mauro and President
Rajiv Malik sold shares of MYL stock. Director Randall L
Vanderveen and Executive Chairman Robert J Coury sold shares in
May. Executive Chairman Robert J Coury sold 150,000 shares in
April and CEO Heather M Bresch sold 197,306 shares in March.
Pfizer Inc. (
PFE
) Reached the 52-Week High of $23.86
The prices of Pfizer Inc. shares have reached $23.86, which is
1.8% off the 52-week high of $24.28. Pfizer Inc. is a
research-based, global pharmaceutical company that discovers and
develops innovative, value-added products that improve the
quality of life of people around the world and help them enjoy
longer, healthier, and more productive lives. Pfizer Inc. has a
market cap of $178.67 billion; its shares were traded at around
$23.86 with a P/E ratio of 10.28 and P/S ratio of 2.65. The
dividend yield of Pfizer Inc. stocks is 3.69%. Pfizer Inc. had an
annual average earnings growth of 0.5% over the past 10 years.
On July 31, Pfizer Inc. reported financial results for
second-quarter 2012. Second-quarter 2012 revenues were $15.1
billion, a decrease of 9% compared with $16.5 billion in the
year-ago quarter, which reflects an operational decline of $977
million, or 6%, and the unfavorable impact of foreign exchange of
$451 million, or 3%. For second-quarter 2012, U.S. revenues were
$5.7 billion, a decrease of 15% compared with the year-ago
quarter. This decrease was primarily the result of the U.S. loss
of exclusivity of Lipitor on November 30, 2011. International
revenues were $9.3 billion, a decrease of 5% compared with the
prior-year quarter, primarily due to the unfavorable impact of
foreign exchange. U.S. revenues represented 38% of total revenues
in second-quarter 2012 compared with 41% in the year-ago quarter,
while international revenues represented 62% of total revenues in
second-quarter 2012 compared with 59% in the year-ago quarter.
In May, Executive Vice President Douglas M Lankler sold 19,670
shares of PFE stock. Executive Vice President Charles H Hill sold
10,400 shares in March.About GuruFocus: GuruFocus.com tracks the
stocks picks and portfolio holdings of the world's best
investors. This value investing site offers stock screeners and
valuation tools. And publishes daily articles tracking the latest
moves of the world's best investors. GuruFocus also provides
promising stock ideas in 3 monthly newsletters sent to
Premium Members
.